Skip to main content
. 2016 Nov 25;8(3):4875–4887. doi: 10.18632/oncotarget.13608

Table 7. Univariate analysis of combined phosphorylated AR sites and disease-specific survival.

Univariate analysis
Disease-specific survivalP value Hazard Ratio (95% CI)
Total pARS578 0.002, 2.20, (1.4-3.5)
Total pARS81 0.034, 1.78, (1.1-2.7)
pARS578 cytoplasmic + pARS81 cytoplasmic <0.001, 2.88, (1.7-5.0)
pARS578 nuclear + pARS81 nuclear 0.011, 1.85, (1.2-2.9)
Total pARS578 + Total pARS81 0.005, 1.76, (1.3-2.4)

Univariate analysis of total and combine pAR protein expression was carried out using Kaplan Meier methods with reference to disease-specific survival.